<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/202897-a-process-for-preparation-of-valdecoxib-crystalline-polymorphs by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 02:13:51 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 202897:A PROCESS FOR PREPARATION OF VALDECOXIB CRYSTALLINE POLYMORPHS</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">A PROCESS FOR PREPARATION OF VALDECOXIB CRYSTALLINE POLYMORPHS</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The present invention relates to novel crystalline forms of valdecoxib, to processes for their preparation and to pharmaceutical compositions containing them.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>The present invention relates to novel crystalline forms of valdecoxib, to processes for their preparation and to phannaceutical compositions containing them.<br>
BACKGROUND OF THE INVENTION Valdecoxib of formula (1):<br><br>
or 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide is a highly selective and potent cyclooxygenase-2 inhibitor in human whole blood and useful for the treatment of arthritis and pain. The therapeutic uses of valdecoxib are disclosed in WO 9625405.<br>
Two crystalline forms of valdecoxib, form A and fond B, are mentioned in WO 9806708.<br>
We have discovered three stable novel crystalline forms of valdecoxib and these forms are found to be suitable for pharmaceutical preparations.<br>
The object of the present invention is to provide stable novel crystalline forms of valdecoxib, processes for preparing these forms and pharmaceutical compositions containing them.<br>
DETAILED DESCRIPTION OF THE INVENTION<br>
In accordance with the present invention, there is provided a novel crystalline form of valdecoxib, designated as form I, characterized by an x-ray<br><br>
powder diffraction pattern having peaks expressed as 20 at about 9.7, 13.1, 14.0, 14.5, 17.0, 17.1, 17.7, 19.4, 20.9, 21.3, 21.8, 24.1, 25.4, 26.3 and 29.1 degrees. Figure 1 shows typical form I x-ray powder diffraction pattern.<br>
In accordance with the present invention, a process is provided for preparation of valdecoxib form I. In this process, valdecoxib is dissolved in dimethyl fonnamide or N,N-dimethyl acetamide and valdecoxib form \ is isolated from the solution. Valdecoxib in any crystalline form may be used. If valdecoxib form I is used in the process, its serves as a method of purification of valdecoxib form 1. A mixture of dimethyl formamide and N,N"dimethyl acetamide; or dimethyl formamide or N,N-dimethyl acetamide mixed with any other solvent may be used. Valdecoxib form I can be isolated by the techniques like cooling, partial removal of the solvent or combination thereof. Crystallization may be initiated with the aid of seed crystals. Preferably, valdecoxib is mixed with dimethyl formamide or N,N-dimethyl acetamide and heated to about 50°C to reflux temperature. The solution so formed is preferably maintained at 25*^0 to • 30°C for 3 to 5 hours and the valdecoxib form I crystals formed are separated by filtration or centrifugation.<br>
In accordance with the present invention, there is provided a novel crystalline form of valdecoxib, designated as form II, characterized by an x-ray powder diffraction pattern having peaks expressed as 26 at about 12.2, 15.4, 15.9, 19.9, 20.6, 22.0, 23.0, 23.6, 23.9, 24.5, 25.1, 28.6 and 31.3 degrees. Figure 2 shows typical form II x-ray powder diffraction pattern.<br>
In accordance with the present invention, a process is provided for preparation of valdecoxib form II. In this process, valdecoxib is dissolved in acetonitrile and isolated valdecoxib form II from the solution. Valdecoxib in any crystalline form may be used. Preferably valdecoxib is dissolved in acetonitrile at about 40°C to 45°C and valdecoxib form II is separated at about 25°C - 30°C. The valdecoxib form II may be collected by filtration or centrifugation.<br>
In accordance with the present invention, there is provided a novel crystalline form of valdecoxib, designated as form III, characterized by an x-ray powder diffraction pattern having peaks expressed as 29 at about 11.6, 12.2, 12.9, 13.3, 15.4, 15.7, 16.7, 17.0, 17.4, 18.1, 19.7, 20.6, 21.9, 22.4, 23.1, 23.4, 23.8, 24.4, 25.3, 25.7, 26,1, 28.5 and 29.7 degrees. Figure 3 shows typical fonri III x-ray powder diffraction pattern.<br><br>
In accordance with the present invention, a process is provided for preparation of valdecoxib form III. In this process, valdecoxib is dissolved in an ester solvent and isolated valdecoxib four III from the solution. Preferably the solution is cooled to 5°C to 30°C to get the crystals of valdecoxib form III. The valdecoxib form III may be collected by filtration or centrifugation. Valdecoxib in any crystalline form may be used in the process. The suitable ester solvent is selected from n-butyl acetate, ethyl acetate, methyl acetate, isopropyl acetate, tert-butyl acetate, ethyl formate, methyl formate. A combination of the ester solvents may also be used.<br>
In accordance with the present invention, there is provided a pharmaceutical composition comprising form I of valdecoxib and a pharmaceutically acceptable carrier or diluent.<br>
In accordance with the present invention, . there is provided a pharmaceutical composition comprising form II of valdecoxib and a pharmaceutically acceptable cannier or diluent.<br>
In accordance with the present invention, there is provided a pharmaceutical composition comprising form III of valdecoxib and a pharmaceutically acceptable cannier or diluent.<br>
BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a x-ray powder diffraction spectrum of valdecoxib form I. Figure 2 is a x-ray powder diffraction spectrum of valdecoxib form II. Figure 3 is a x-ray powder diffraction spectrum of valdecoxib form III. x-Ray powder diffraction spectrum was measured on a Sidemen’s D5000 x-ray powder diffract meter having a copper-Ka radiation.<br>
The following examples are given for the purpose of illustrating the present invention and should not be considered as limitations on the scope of spirit of the invention.<br>
Example 1 Valdecoxib (10 gm, obtained by the process described in example 1 of WO 9625405) is dissolved in dimethyl formamide (50 ml), heated to 50°C and<br><br>
the solution obtained is cooled to 25°C and maintained at 25°C to 30°C for 3 hours. The separated crystals are filtered to give 9 gm of valdecoxib form I.<br>
Example 2 Valdecoxib (10 gm) is dissolved in acetonitrile (125 ml), heated to 40°C and the solution obtained is cooled to 25°C and maintained at 25°C to 30°C for 6 hours. The separated crystals are filtered to give 9.5 gm of valdecoxib form II.<br>
Example 3 Example 1 is repeated using valdecoxib form II for valdecoxib to give valdecoxib form I.<br>
Example 4 Example 2 is repeated using valdecoxib form I for valdecoxib to give valdecoxib form II.<br>
Example 5 Valdecoxib (10 gm) is mixed with n-butyl acetate (100 ml), heated to 80°C. The solution so formed is cooled to 25°C and maintained at about 25°C for 5 hours. The separated crystals are filtered to give 8.5 gm of valdecoxib form III.<br>
Example 6 Example 5 is repeated using valdecoxib form II for valdecoxib to give valdecoxib form Dill.<br><br><br><br>
We claim:<br>
1.	A process for the preparation of the valdecoxib crystalline polymorph, form I,<br>
characterized by an x-ray powder diffraction pattern having peaks expressed<br>
as 26 at about 9.7, 13.1, 14.0, 14.5. 17.0, 17.1, 17.7; 19.4. 20.9, 21.3, 21.8,<br>
24.1, 25.4, 26.3 and 29.1 degrees as shown in figure 1; fame II,<br>
characterized by an x-ray powder diffraction pattern having peaks expressed<br>
as 29 at about 12.2, 15.4, 15.9, 19.9, 20.6, 22.0, 23.0, 23.6, 23.9, 24.5, 25.1,<br>
28.6 and 31.3 degrees as shown in figure 2; and form III, characterized by<br>
an x-ray powder diffraction pattern having peaks expressed as 29 at about<br>
11.6, 12.2, 12.9. 13.3, 15.4, 15.7, 16.7, 17.0, 17.4, 18.1. 19.7. 20.6. 21.9,<br>
22.4, 23.1, 23.4, 23.8, 24.4, 25.3, 25.7, 26.1, 28.5 and 29.7 degrees as<br>
shown in figure 3; as herein described comprising the steps of:<br>
a)	dissolving valdecoxib in a solvent selected either from dimethylformamide and N,N-dimethylacetamide at 50°C to reflux temperature or from acetonitrile at 40 - 45°C or from an ester solvent such as n-butyl acetate, ethyl acetate, methyl acetate, isopropyl acetate, tert-butyl acetate, ethyl fonnat and methyl format; and<br>
b)	isolating the valdecoxib crystalline form I at 25 - 30°C or valdecoxib crystalline form II at 25 - 30°C or valdecoxib crystalline form III at 25 -30°C by a conventional method.<br><br>
2.	The process as claimed in claim 1, wherein the separated crystals formed in step-(b) are collected by filtration or centrifugation.<br>
3.	The process as claimed in claim 1, wherein the process comprising the steps of:<br><br>
a)	dissolving valdecoxib in dimethylformamide or N,N-dimethylacetamide at 50°C to reflux temperature; and<br>
b)	isolating the valdecoxib crystalline form I from the solution obtained in step-(a) at 25 - 30°C by a conventional method.<br><br>
4.	The process as claimed in claim 3, wherein the separated crystals formed in step-(b) are collected by filtration or centrifugation.<br>
5.	The process as claimed in claim 1, wherein the process comprising the steps of:<br>
a) dissolving valdecoxib in acetonitrile at 40 - 45°C; and<br><br>
b)  isolating the valdecoxib crystalline form II from the solution obtained in step-(a) at 25 - 30°C by a conventional method.<br>
6.	The process as claimed in claim 5, wherein the separated crystals formed in<br>
step-(b) are collected by filtration or centrifugation.<br>
7.	The process as claimed in claim 1, wherein the process comprising the steps<br>
of:<br>
a)	dissolving valdecoxib in an ester solvent; and<br>
b)	isolating the desired crystalline polymorph form III of valdecoxib from the<br>
solution obtained in step-(a) by a conventional method.<br>
8.	The process as claimed in claim 7, wherein the ester solvent is selected from<br>
n-butyl acetate, ethyl acetate, methyl acetate, isopropyl acetate, tert-butyl<br>
acetate, ethyl formate and methyl formate.<br>
9.	The process as claimed in claim 8, wherein the ester solvent is n-butyl<br>
acetate.<br>
10.	The process as claimed in claim 7, wherein the separated crystals formed in<br>
step-(b) are collected by filtration or centrifugation.<br>
11.	The process as claimed in claim 1, wherein the solvent used in step-(a) is in<br>
the ratio of at least about 4 parts of the solvent to 1 part of the said<br>
valdecoxib by weight.<br>
12.	The process as claimed in claim 11, wherein the solvent is in the ratio of at<br>
least about 8 parts of the solvent to 1 part of the said valdecoxib by weight<br><br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODI3LWNoZW5wLTIwMDMtYWJzdHJhY3QucGRm" target="_blank" style="word-wrap:break-word;">827-chenp-2003-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODI3LWNoZW5wLTIwMDMtY2xhaW1zIGZpbGVkLnBkZg==" target="_blank" style="word-wrap:break-word;">827-chenp-2003-claims filed.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODI3LWNoZW5wLTIwMDMtY2xhaW1zIGdyYW50ZWQucGRm" target="_blank" style="word-wrap:break-word;">827-chenp-2003-claims granted.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODI3LWNoZW5wLTIwMDMtY29ycmVzcG9uZG5lY2Utb3RoZXJzLnBkZg==" target="_blank" style="word-wrap:break-word;">827-chenp-2003-correspondnece-others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODI3LWNoZW5wLTIwMDMtY29ycmVzcG9uZG5lY2UtcG8ucGRm" target="_blank" style="word-wrap:break-word;">827-chenp-2003-correspondnece-po.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODI3LWNoZW5wLTIwMDMtZGVzY3JpcHRpb24oY29tcGxldGUpIGZpbGVkLnBkZg==" target="_blank" style="word-wrap:break-word;">827-chenp-2003-description(complete) filed.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODI3LWNoZW5wLTIwMDMtZGVzY3JpcHRpb24oY29tcGxldGUpIGdyYW50ZWQucGRm" target="_blank" style="word-wrap:break-word;">827-chenp-2003-description(complete) granted.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODI3LWNoZW5wLTIwMDMtZHJhd2luZ3MucGRm" target="_blank" style="word-wrap:break-word;">827-chenp-2003-drawings.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODI3LWNoZW5wLTIwMDMtZm9ybSAxLnBkZg==" target="_blank" style="word-wrap:break-word;">827-chenp-2003-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODI3LWNoZW5wLTIwMDMtZm9ybSAzLnBkZg==" target="_blank" style="word-wrap:break-word;">827-chenp-2003-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODI3LWNoZW5wLTIwMDMtZm9ybSA0LnBkZg==" target="_blank" style="word-wrap:break-word;">827-chenp-2003-form 4.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODI3LWNoZW5wLTIwMDMtZm9ybSA1LnBkZg==" target="_blank" style="word-wrap:break-word;">827-chenp-2003-form 5.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="202896-molding-tool-formed-of-gradient-composite-material-and-method-of-producing-the-same.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="202898-water-supply-unit.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>202897</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>827/CHENP/2003</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>30/2009</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>24-Jul-2009</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>30-Oct-2006</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>28-May-2003</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>M/S. HETERO DRUGS LIMITED</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>Hetero House, 8-3-166/7/1, Erragadda, Hyderabad 500 018</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>PARTHASARADHI, Reddy, Bandi</td>
											<td>Hetero House, 8-3-166/7/1, Erragadda, Hyderabad 500 018</td>
										</tr>
										<tr>
											<td>2</td>
											<td>RATHNAKAR, Reddy, Kura</td>
											<td>Hetero Drugs Limited (R &amp; D), Plot No. B-80 &amp; 81, A.P.I.E., Balanagar, Hyderabad 500 018,</td>
										</tr>
										<tr>
											<td>3</td>
											<td>RAJI, Reddy, Rapolu</td>
											<td>Hetero Drugs Limited (R &amp; D), Plot No. B-80 &amp; 81, A.P.I.E., Balanagar, Hyderabad 500 018</td>
										</tr>
										<tr>
											<td>4</td>
											<td>MURALIDHARA, Reddy, Dasari</td>
											<td>Hetero Drugs Limited (R &amp; D), Plot No. B-80 &amp; 81, A.P.I.E., Balanagar, Hyderabad 500 018,</td>
										</tr>
										<tr>
											<td>5</td>
											<td>SUBASH CHANDER, Reddy, Kesireddy</td>
											<td>Hetero Drugs Limited (R &amp; D), Plot No. B-80 &amp; 81, A.P.I.E., Balanagar, Hyderabad 500 018</td>
										</tr>
										<tr>
											<td>6</td>
											<td>PARTHASARADHI, Reddy, Bandi</td>
											<td>Hetero House, 8-3-166/7/1, Erragadda, Hyderabad 500 018</td>
										</tr>
										<tr>
											<td>7</td>
											<td>RATHNAKAR, Reddy, Kura</td>
											<td>Hetero Drugs Limited (R &amp; D), Plot No. B-80 &amp; 81, A.P.I.E., Balanagar, Hyderabad 500 018,</td>
										</tr>
										<tr>
											<td>8</td>
											<td>RAJI, Reddy, Rapolu</td>
											<td>Hetero Drugs Limited (R &amp; D), Plot No. B-80 &amp; 81, A.P.I.E., Balanagar, Hyderabad 500 018</td>
										</tr>
										<tr>
											<td>9</td>
											<td>MURALIDHARA, Reddy, Dasari</td>
											<td>Hetero Drugs Limited (R &amp; D), Plot No. B-80 &amp; 81, A.P.I.E., Balanagar, Hyderabad 500 018,</td>
										</tr>
										<tr>
											<td>10</td>
											<td>SUBASH CHANDER, Reddy, Kesireddy</td>
											<td>Hetero Drugs Limited (R &amp; D), Plot No. B-80 &amp; 81, A.P.I.E., Balanagar, Hyderabad 500 018</td>
										</tr>
										<tr>
											<td>11</td>
											<td>PARTHASARADHI, Reddy, Bandi</td>
											<td>Hetero House, 8-3-166/7/1, Erragadda, Hyderabad 500 018</td>
										</tr>
										<tr>
											<td>12</td>
											<td>RATHNAKAR, Reddy, Kura</td>
											<td>Hetero Drugs Limited (R &amp; D), Plot No. B-80 &amp; 81, A.P.I.E., Balanagar, Hyderabad 500 018,</td>
										</tr>
										<tr>
											<td>13</td>
											<td>RAJI, Reddy, Rapolu</td>
											<td>Hetero Drugs Limited (R &amp; D), Plot No. B-80 &amp; 81, A.P.I.E., Balanagar, Hyderabad 500 018</td>
										</tr>
										<tr>
											<td>14</td>
											<td>MURALIDHARA, Reddy, Dasari</td>
											<td>Hetero Drugs Limited (R &amp; D), Plot No. B-80 &amp; 81, A.P.I.E., Balanagar, Hyderabad 500 018,</td>
										</tr>
										<tr>
											<td>15</td>
											<td>SUBASH CHANDER, Reddy, Kesireddy</td>
											<td>Hetero Drugs Limited (R &amp; D), Plot No. B-80 &amp; 81, A.P.I.E., Balanagar, Hyderabad 500 018</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07D261/08</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/IN2003/000139</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2003-04-04</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td></td>
									<td></td>
								    <td>NA</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/202897-a-process-for-preparation-of-valdecoxib-crystalline-polymorphs by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 02:13:52 GMT -->
</html>
